Digital Joint Assessments—How Purpose-Built eCOA Solutions Improve Clinical Research

Joint inflammation is a core symptom across a range of chronic conditions, including psoriatic arthritis, ankylosing spondylitis, and other autoimmune or musculoskeletal diseases. As global prevalence continues to rise, so does the need for effective, targeted therapies. Advancing these therapies depends on clinical trials that can reliably capture disease activity and treatment response, making efficient joint assessments crucial for treatment development across these conditions. Researchers have long faced challenges with traditional joint assessment methods, creating bottlenecks in clinical research.

This YPrime brief explores the challenges researchers face and demonstrates how, when done right, eCOA joint assessments can improve data capture, enhancing patient outcomes across multiple indications.

Improving Joint Assessments in Clinical Trials

A new approach to Tender Swollen Joint Count (TSJC) assessments is helping clinical teams simplify data capture and improve consistency across sites:

Efficient Data Entry: A tablet-based interface reduces training time and speeds up assessments—without sacrificing accuracy.

Visual Guidance: Real-time anatomical illustrations support more consistent scoring and clearer communication across study teams.

Built-In Quality Controls: Instant calculations and data validation features help ensure accuracy from the start, reducing the need for downstream corrections.

Download the TSJC Brief and discover new ways to improve data capture.

For additional resources and information on how YPrime can improve your clinical trials, visit our YPrime eCOA page and our Tender Swollen Joint Count (TSJC) eCOA assessment page.